NCT06686004

Brief Summary

Carrot is a unique vegetable owing to the availability of bioactive compounds polyacetylenes (PA) as well as carotenoids present in it. These compounds have been shown to be associated with reduced cancer risk in epidemiological-based studies, and also showed anticancer properties in vitro studies and in vivo in mouse and rat models. To investigate whether the PA and carotenoids could have beneficial effects in humans, the present study is designed to determine whether they are detectible in human biofluids after the ingestion of a portion of carrots and whether there is a difference in the magnitude of detection after eating a large (300g) and normal (100g) portion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 3, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 13, 2024

Completed
Last Updated

November 13, 2024

Status Verified

August 1, 2022

Enrollment Period

1 year

First QC Date

November 3, 2024

Last Update Submit

November 10, 2024

Conditions

Keywords

bioavailabilitymetabolismcarrotscarotenoidspolyacetylenesFalcarinolFalcarindiolFalcarindiol-3-acetateα-caroteneβ-caroteneluteinabsorption

Outcome Measures

Primary Outcomes (1)

  • Absorption of PA and carotenoids

    The primary outcome is testing whether a change in concentration of PA and carotenoids is seen between baseline and various time points in the biofluids after ingesting carrots.

    48hr

Secondary Outcomes (1)

  • Dose-effect between the absorption of PA and carotenoids from 100g and 300g carrots

    48hr

Study Arms (2)

High dose (300g) carrot with 2 slices of bread and 10g butter

ACTIVE COMPARATOR

Test Session 2: The participants will consume the 300g carrots with bread and butter. This is considered a reasonable high enough dose that detection of the compounds must occur. This dose would be compared with the normal dose (100g) to see if there is more absorption of the compound when eaten a hiher dose.

Dietary Supplement: Carrots

Experimental: Normal dose (100g) carrot with 2 slices of bread and 10g butter

ACTIVE COMPARATOR

Test session 1: This is a normal dose (100g) which would be compared with the high dose to see if there dose-dependent effect in the magnitude of absorption. Test Session 2: All the process as in the test session 1 will be repeated for the 300g dose carrot.

Dietary Supplement: Carrots

Interventions

CarrotsDIETARY_SUPPLEMENT

Detection of polyacetylene and carotenoids in human biofluids

Also known as: PA: falcarinol, falcarindiol, falcarindiol-3-acetate, Carotenoids: α-carotene, β-carotene, lutein
Experimental: Normal dose (100g) carrot with 2 slices of bread and 10g butterHigh dose (300g) carrot with 2 slices of bread and 10g butter

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adults 20+ years old.
  • Having body mass index (BMI) between ≥18.5 - ≤30 kg/m2.
  • Must be willing to eat a portion (100g) of carrot in the test session 1, alongside 2 slices of bread with 10g butter.
  • Must be willing to eat a portion (300g) of carrot in the test session 2, alongside 2 slices of bread with 10g butter.

You may not qualify if:

  • Having any metabolic or gastrointestinal conditions.
  • Having allergies to carrot or bread or butter.
  • Taking any medication that affects metabolism or digestion.
  • Smokers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nutrtition Suite, DMBB Newcastle University

Newcastle upon Tyne, Tyne and Wear, NE2 4HH, United Kingdom

Location

MeSH Terms

Interventions

falcarindiolLutein

Intervention Hierarchy (Ancestors)

XanthophyllsCarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesPigments, BiologicalBiological Factors

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SCREENING
Intervention Model
CROSSOVER
Model Details: Active comparator: orange carrot 100g or 300g Placebo comparator: baseline - before ingestion
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2024

First Posted

November 13, 2024

Study Start

August 1, 2022

Primary Completion

August 10, 2023

Study Completion

September 30, 2024

Last Updated

November 13, 2024

Record last verified: 2022-08

Locations